Literature DB >> 25342615

Identifying "preperimetric" glaucoma in standard automated perimetry visual fields.

Ryo Asaoka1, Aiko Iwase2, Kazunori Hirasawa3, Hiroshi Murata1, Makoto Araie4.   

Abstract

PURPOSE: To compare the visual fields (VFs) of preperimetric open angle glaucoma (OAG) patients (preperimetric glaucoma VFs, PPGVFs) with the VFs of healthy eyes, and to discriminate these two groups by using the Random Forests machine-learning method.
METHODS: All VFs before a first diagnosis of manifest glaucoma (Anderson-Patella's criteria) were classified as PPGVFs. Series of VFs were obtained with the Humphrey Field Analyzer 30-2 program from 171 PPGVFs from 53 eyes in 51 OAG or OAG suspect patients and 108 healthy eyes of 87 normal subjects. The area under the receiver operating characteristic curve (AROC) in discriminating between PPGVFs and healthy VFs was calculated by using the Random Forests method, with 52 total deviation (TD) values, mean deviation (MD), and pattern standard deviation (PSD) as predictors.
RESULTS: There was a significant difference in MD between healthy VFs and PPGVFs (-0.03 ± 1.11 and -0.91 ± 1.56 dB [mean ± standard deviation], respectively; P < 0.001, linear mixed model) and in PSD (1.56 ± 0.33 and 1.97 ± 0.43 dB, respectively; P < 0.001). A significant difference was observed in the TD values between healthy VFs and PPGVFs at 25 (P < 0.001) of 52 test points (linear mixed model). The AROC obtained by using the Random Forests method was 79.0% (95% confidence interval, 73.5%-84.5%).
CONCLUSIONS: Differences exist between healthy VFs and VFs of preperimetric glaucoma eyes, which go on to develop manifest glaucoma; these two groups of VFs could be well distinguished by using the Random Forests classifier. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  Random Forests method; glaucoma; preperimetric stage; visual field

Mesh:

Year:  2014        PMID: 25342615     DOI: 10.1167/iovs.14-15120

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Hybrid Deep Learning on Single Wide-field Optical Coherence tomography Scans Accurately Classifies Glaucoma Suspects.

Authors:  Hassan Muhammad; Thomas J Fuchs; Nicole De Cuir; Carlos G De Moraes; Dana M Blumberg; Jeffrey M Liebmann; Robert Ritch; Donald C Hood
Journal:  J Glaucoma       Date:  2017-12       Impact factor: 2.503

2.  Development of visual field defect after first-detected optic disc hemorrhage in preperimetric open-angle glaucoma.

Authors:  Hae Jin Kim; Yong Ju Song; Young Kook Kim; Jin Wook Jeoung; Ki Ho Park
Journal:  Jpn J Ophthalmol       Date:  2017-03-29       Impact factor: 2.447

3.  Rationale and Development of an OCT-Based Method for Detection of Glaucomatous Optic Neuropathy.

Authors:  Jeffrey M Liebmann; Donald C Hood; Carlos Gustavo de Moraes; Dana M Blumberg; Noga Harizman; Yocheved S Kresch; Emmanouil Tsamis; George A Cioffi
Journal:  J Glaucoma       Date:  2022-02-28       Impact factor: 2.290

4.  Prediction of Visual Field Progression from OCT Structural Measures in Moderate to Advanced Glaucoma.

Authors:  Kouros Nouri-Mahdavi; Vahid Mohammadzadeh; Alessandro Rabiolo; Kiumars Edalati; Joseph Caprioli; Siamak Yousefi
Journal:  Am J Ophthalmol       Date:  2021-01-30       Impact factor: 5.488

5.  A Case for the Use of Artificial Intelligence in Glaucoma Assessment.

Authors:  Joel S Schuman; Maria De Los Angeles Ramos Cadena; Rebecca McGee; Lama A Al-Aswad; Felipe A Medeiros
Journal:  Ophthalmol Glaucoma       Date:  2021-12-22

Review 6.  The value of visual field testing in the era of advanced imaging: clinical and psychophysical perspectives.

Authors:  Jack Phu; Sieu K Khuu; Michael Yapp; Nagi Assaad; Michael P Hennessy; Michael Kalloniatis
Journal:  Clin Exp Optom       Date:  2017-06-22       Impact factor: 2.742

7.  Relationship between Vision-Related Quality of Life and Central 10° of the Binocular Integrated Visual Field in Advanced Glaucoma.

Authors:  Yoshio Yamazaki; Kenji Sugisaki; Makoto Araie; Hiroshi Murata; Akiyasu Kanamori; Toshihiro Inoue; Shinichiro Ishikawa; Keiji Yoshikawa; Hidetaka Maeda; Yuko Yamada; Akira Negi; Masaru Inatani; Hidenobu Tanihara; Satoshi Okinami; Kenji Mizuki; Koichi Mishima; Kenichi Uchida; Shun Matsumoto
Journal:  Sci Rep       Date:  2019-10-18       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.